These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 10502590

  • 1. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    N Engl J Med; 1999 Sep 30; 341(14):1013-20. PubMed ID: 10502590
    [Abstract] [Full Text] [Related]

  • 2. DHEA replacement in women with adrenal insufficiency--pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
    Arlt W, Callies F, Allolio B.
    Endocr Res; 2000 Nov 30; 26(4):505-11. PubMed ID: 11196420
    [Abstract] [Full Text] [Related]

  • 3. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G, Bengtsson C, Larsson A, Karlsson FA, Sturfelt G, Rönnblom L.
    Autoimmunity; 2005 Nov 30; 38(7):531-40. PubMed ID: 16373258
    [Abstract] [Full Text] [Related]

  • 4. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B.
    Climacteric; 2002 Dec 30; 5(4):357-65. PubMed ID: 12626215
    [Abstract] [Full Text] [Related]

  • 5. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr 30; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 6. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 30; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 7. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion.
    Arlt W, Callies F, Koehler I, van Vlijmen JC, Fassnacht M, Strasburger CJ, Seibel MJ, Huebler D, Ernst M, Oettel M, Reincke M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 2001 Oct 30; 86(10):4686-92. PubMed ID: 11600526
    [Abstract] [Full Text] [Related]

  • 8. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G, Weber S, Ehrismann M, Zaiser N, Meisner C, Ranke MB, Maier L, Wudy SA, Hartmann MF, Heinrich U, Bettendorf M, Doerr HG, Pfaeffle RW, Keller E, South German Working Group for Pediatric Endocrinology.
    J Clin Endocrinol Metab; 2009 Apr 30; 94(4):1182-90. PubMed ID: 19126625
    [Abstract] [Full Text] [Related]

  • 9. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
    Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, Bell RJ.
    Menopause; 2006 Apr 30; 13(1):37-45. PubMed ID: 16607097
    [Abstract] [Full Text] [Related]

  • 10. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.
    Rice SP, Agarwal N, Bolusani H, Newcombe R, Scanlon MF, Ludgate M, Rees DA.
    J Clin Endocrinol Metab; 2009 Jun 30; 94(6):1966-72. PubMed ID: 19318448
    [Abstract] [Full Text] [Related]

  • 11. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.
    Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR.
    Menopause; 2003 Jun 30; 10(5):390-8. PubMed ID: 14501599
    [Abstract] [Full Text] [Related]

  • 12. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B.
    J Endocrinol Invest; 2004 Sep 30; 27(8):736-41. PubMed ID: 15636426
    [Abstract] [Full Text] [Related]

  • 13. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep 30; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 14. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May 30; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 15. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec 30; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 16. Dehydroepiandrosterone for adrenal insufficiency.
    Oelkers W.
    N Engl J Med; 1999 Sep 30; 341(14):1073-4. PubMed ID: 10502598
    [No Abstract] [Full Text] [Related]

  • 17. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B.
    J Clin Endocrinol Metab; 2001 May 30; 86(5):1968-72. PubMed ID: 11344193
    [Abstract] [Full Text] [Related]

  • 18. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
    Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA.
    N Engl J Med; 2000 Sep 07; 343(10):682-8. PubMed ID: 10974131
    [Abstract] [Full Text] [Related]

  • 19. Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
    Christiansen JJ, Andersen NH, Sørensen KE, Pedersen EM, Bennett P, Andersen M, Christiansen JS, Jørgensen JO, Gravholt CH.
    Clin Endocrinol (Oxf); 2007 Mar 07; 66(3):426-33. PubMed ID: 17302879
    [Abstract] [Full Text] [Related]

  • 20. Effects of dehydroepiandrosterone sulphate (DHEAS) replacement on insulin action and quality of life in hypopituitary females: a double-blind, placebo-controlled study.
    McHenry CM, Bell PM, Hunter SJ, Thompson CJ, Courtney CH, Ennis CN, Sheridan B, McCance DR, Mullan KR, Atkinson AB.
    Clin Endocrinol (Oxf); 2012 Sep 07; 77(3):423-9. PubMed ID: 22420492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.